IP Library Patent Application 10567595
Patent Application
App. No. 10/567,595

Erythrocytic cells and method for loading solutes

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
10/567,595
Abstract

A dehydrated composition is provided that includes freeze-dried erythrocytic cells. The invention further provides methods for loading a solute into a cell comprising disposing a cell in a solution having a solute concentration of sufficient magnitude to produce hyperosmotic pressure on the cell for transferring a solute from the solution into cell.

Claims (41)

1 . A method for loading a solute into an erythrocytic cell, comprising:

disposing an erythrocytic cell in a solution having a solute concentration of sufficient magnitude to produce hyperosmotic pressure on the cell, thereby transferring a solute from the solution into the cell.

2 . The method of claim 1 wherein said solute is present in said solution in a concentration of between 700 and 1000 mM.

3 . The method of claim 1 , wherein said solute is a disaccharide.

4 . The method of claim 3 , wherein said disaccharide is trehalose.

5 . The method of claim 1 , wherein said solution further comprises a potassium salt.

6 . The method of claim 5 , wherein said potassium salt is potassium phosphate.

7 . The method of claim 1 , wherein said solution further comprises α-crystallin.

8 . The method of claim 1 , wherein said solution further comprises a strong reducing agent.

9 . The method of claim 8 , wherein said strong reducing agent is ascorbic acid.

10 . The method of claim 1 , wherein said solution comprises a disaccharide, a-crystallin, ascorbic acid, and a potassium salt.

11 . A method of claim 1 , further wherein the loading is conducted at a temperature of between 25 and 40° C.

12 . A method of claim 11 , further wherein the loading is conducted at a temperature of between 30 and 40° C.

13 . A method of claim 11 , further wherein the loading is conducted at a temperature of about 37° C.

14 . An erythrocyte loaded with from 10 mM to 50 mM trehalose.

15 . An erythrocyte of claim 11 , further comprising ascorbic acid.

16 . An erythrocyte of claim 11 , further comprising α-crystallin.

17 . A method for separating fragile or damaged cells from a population of erythrocytes, said method comprising

contacting said population with a first solution which is hyperosmotic with respect to a solute,

loading a solute into said erythrocytes,

removing said erythrocytes from said hyperosmotic solution,

contacting said erythrocytes with a second solution which is mildly hypoosmotic in comparison to said hyperosmotic solution, thereby lysing fragile or damaged cells, and

separating said fragile or damaged cells from said population.

18 . A method of claim 14 , wherein said separation is by centrifugation.

19 . A method for freeze-drying erythrocytes comprising lowering the hematocrit of said erythrocytes to between 2 and 5%.

20 . A method for freeze-drying erythrocytes, comprising drying said erythrocytes in the presence of liposomes.

21 . A method of claim 18 , wherein said liposomes are composed primarily of unsaturated lipids.

22 . A method for freeze-drying erythrocytes, comprising freeze-drying said erythrocytes in the presence of 200-300 mOsm of potassium salts.

23 . A method of claim 19 , wherein said erythrocytes are present in a hematocrit of up to 15%.

24 . A buffer for drying erythrocytes, said buffer comprising liposomes.

25 . A buffer of claim 21 , wherein said liposomes are composed primarily of unsaturated lipids.

26 . A buffer for drying erythrocytes, said buffer comprising ascorbic acid.

27 . A buffer for rehydrating dried erythrocytes, said buffer comprising methylene blue.

28 . A buffer for rehydrating dried erythrocytes, said buffer comprising transition metal ions.

29 . A buffer of claim 24 , wherein said transition metal ions are selected from the group consisting of zinc, copper, magnesium, and nickel.

30 . A solution for rehydrating dried erythrocytes, said solution comprising ascorbic acid.

31 . A solution for rehydrating dried erythrocytes, said solution comprising methylene blue, ascorbic acid, and transition metal ions.

32 . A method for rehydrating dried erythrocytes, said method comprising contacting said dried erythrocytes with a solution comprising methylene blue.

33 . A method for rehydrating dried erythrocytes, said method comprising contacting said dried erythrocytes with a solution comprising transition metal ions.

34 . A method for rehydrating dried erythrocytes, said method comprising contacting said dried erythrocytes with a solution comprising ascorbic acid.

35 . A method for rehydrating dried erythrocytes, said method comprising contacting said dried erythrocytes with a solution comprising methylene blue, and transition metal ions.

Assignments (2)
CONFIRMATORY LICENSE Recorded Sep 17, 2010
From: UNIVERSITY OF CALIFORNIA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 025004/0518 →
CONFIRMATORY LICENSE Recorded Oct 17, 2008
From: REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE
To: NAVY, SECRETARY OF THE UNITED STATES
Reel/Frame 021699/0156 →